MarketPeel
Insider Trading Intelligence
RB

Robert Charles Breedlove

PHAT
PRINCIPAL ACCOUNTING OFFICER · PHATHOM PHARMACEUTICALS, INC. · CIK 0002066645
FILING MIX · LIFETIME30%/70%
BUYS
3
SELLS
7
TOTAL VALUE
$58.4K
COMPANIES
1
ACTIVE SINCE
May 2025
HOLDINGS NOW
61,894
AVG SELL PX
$11.54
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Robert Charles Breedlove, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+33.33%-0.39%+0.96%-1.35%+0.28%
14d3+33.33%+0.12%+0.53%-0.41%+2.92%
30d3+33.33%+7.95%+2.31%+5.64%+6.77%
60d3+0.00%+20.52%+3.39%+17.13%+14.45%
90d3+0.00%+23.26%+4.53%+18.72%+13.38%
180d3+66.67%+16.94%+7.56%+9.38%-16.23%
1y3(3 pending)
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PHAT · 61,894 shares · as of Feb 27, 2026
015,71531,42947,14462,8582026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2026
FLOW · 3 buys / 7 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PHAT
PHATHOM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
13,00060,068Feb 27, 2026Mar 3, 2026View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,79062,858Feb 27, 2026Mar 3, 2026View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
SALE
Principal Accounting Officer
414$12.56$5.2K61,480Feb 27, 2026Mar 3, 2026View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
SALE
Principal Accounting Officer
964$12.56$12.1K61,894Feb 27, 2026Mar 3, 2026View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
SALE
Principal Accounting Officer
776$13.61$10.6K47,068Jan 21, 2026Jan 23, 2026View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
SALE
Principal Accounting Officer
230$16.28$3.7K47,844Dec 18, 2025Dec 19, 2025View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
SALE
Principal Accounting Officer
524$13.51$7.1K47,407Nov 3, 2025Nov 5, 2025View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
SALE
Principal Accounting Officer
461$12.09$5.6K47,931Sep 5, 2025Sep 9, 2025View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
SALE
Principal Accounting Officer
1,692$8.36$14.2K48,392Jul 16, 2025Jul 18, 2025View →
PHAT
PHATHOM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
33,00033,000May 19, 2025May 21, 2025View →
Other insiders · PHAT
Loading peer insiders…
About this filer
CIK 0002066645
ROLE
Principal Accounting Officer
PRIMARY
PHAT
COMPANIES
1
ACTIVE SINCE
May 2025
MARKETPEEL · /INSIDER/0002066645DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback